Sundrug Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
43,569.00
41,261.00
37,710.00
34,675.00
37,188.00
34,648.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-8,961.00
-2,057.00
-3,071.00
-294.00
-2,695.00
-1,735.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
41,164.00
41,188.00
37,380.00
31,682.00
31,761.00
32,274.00
Cash Flow from Investing Activities
-35,373.00
-74,850.00
-28,512.00
-20,659.00
-17,901.00
-13,950.00
Cash Flow from Financing Activities
-10,600.00
22,487.00
-17,326.00
-8,187.00
-8,064.00
-7,863.00
Net Cash Inflow / Outflow
-4,743.00
-11,175.00
-8,458.00
2,836.00
5,796.00
10,461.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
66.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sundrug Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
43569
35968.94416
7,601.00
21.13%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-8961
30773
-39,734.00
-129.12%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
41164
64643
-23,479.00
-36.32%
Cash Flow from Investing Activities
-35373
-19713
-15,660.00
-79.44%
Cash Flow from Financing Activities
-10600
-10872
272.00
2.50%
Net Cash Inflow / Outflow
-4743
34051
-38,794.00
-113.93%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
66
-7
73.00
1042.86%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -0.06% vs 10.19% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
41,164.00
41,188.00
-0.06%






